Opportunistic Infections: Clinical Trials

1 trial for Opportunistic Infections, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Terminated 1

Follow Opportunistic Infections: new trials by email Literature Review of Opportunistic Infections trials Research Report on Opportunistic Infections

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety and Effectiveness of Giving L-743,872 to Patients With Thrush That Has Not Been Cured With Fluconazole
L-743,872 - Candidiasis, Oral, HIV Infections
Phase 2TerminatedMerck Sharp & Dohme LLC702005-06-24

Narrower conditions

AIDS-Related Opportunistic Infections (1)  ·  Candidiasis, Oral (1)  ·  HIV Infections (1)  ·  Pharyngeal Diseases (1)

Broader conditions

Bacterial Infections and Mycoses (1)  ·  Blood-Borne Infections (1)  ·  Candidiasis (1)  ·  Communicable Diseases (1)  ·  Genital Diseases (1)  ·  Immune System Diseases (1)  ·  Immunologic Deficiency Syndromes (1)  ·  Infections (1)  ·  Lentivirus Infections (1)  ·  Mouth Diseases (1)  ·  Mycoses (1)  ·  Otorhinolaryngologic Diseases (1)  ·  RNA Virus Infections (1)  ·  Retroviridae Infections (1)

Interventions

Caspofungin (1)

Sponsors

Merck Sharp & Dohme LLC (1)

Countries

United States (1)